JP2024512608A5 - - Google Patents

Info

Publication number
JP2024512608A5
JP2024512608A5 JP2023558899A JP2023558899A JP2024512608A5 JP 2024512608 A5 JP2024512608 A5 JP 2024512608A5 JP 2023558899 A JP2023558899 A JP 2023558899A JP 2023558899 A JP2023558899 A JP 2023558899A JP 2024512608 A5 JP2024512608 A5 JP 2024512608A5
Authority
JP
Japan
Prior art keywords
seq
cells
section
population
manipulated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023558899A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024512608A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/021820 external-priority patent/WO2022204443A1/en
Publication of JP2024512608A publication Critical patent/JP2024512608A/ja
Publication of JP2024512608A5 publication Critical patent/JP2024512608A5/ja
Pending legal-status Critical Current

Links

JP2023558899A 2021-03-24 2022-03-24 Ｔリンパ球における効率的なｔｃｒ遺伝子編集 Pending JP2024512608A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163165509P 2021-03-24 2021-03-24
US63/165,509 2021-03-24
US202263323065P 2022-03-24 2022-03-24
US63/323,065 2022-03-24
PCT/US2022/021820 WO2022204443A1 (en) 2021-03-24 2022-03-24 Efficient tcr gene editing in t lymphocytes

Publications (2)

Publication Number Publication Date
JP2024512608A JP2024512608A (ja) 2024-03-19
JP2024512608A5 true JP2024512608A5 (https=) 2025-03-28

Family

ID=81308117

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023558899A Pending JP2024512608A (ja) 2021-03-24 2022-03-24 Ｔリンパ球における効率的なｔｃｒ遺伝子編集

Country Status (7)

Country Link
US (2) US12239664B2 (https=)
JP (1) JP2024512608A (https=)
KR (1) KR20230160885A (https=)
AU (1) AU2022245323A1 (https=)
BR (1) BR112023019195A2 (https=)
CA (1) CA3214486A1 (https=)
WO (1) WO2022204443A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2023002455A (es) * 2020-08-28 2023-05-16 Arsenal Biosciences Inc Células inmunitarias modificadas con receptores cebadores.
JP2024512608A (ja) 2021-03-24 2024-03-19 ジェネンテック， インコーポレイテッド Ｔリンパ球における効率的なｔｃｒ遺伝子編集
AU2024228388A1 (en) 2023-02-27 2025-10-02 Adaptive Biotechnologies Corp. Therapeutic t cell receptors targeting kras g12d
CN119320771A (zh) * 2023-07-17 2025-01-17 北京艺妙神州医药科技有限公司 用于敲除t细胞中的trac和b2m的试剂和方法
TW202544244A (zh) * 2024-03-06 2025-11-16 美商Ｒ Ｐ 先靈爾科技公司 使用連續遞送對哺乳動物細胞基因工程化之方法
WO2025217891A1 (zh) * 2024-04-19 2025-10-23 深圳市先康达生命科学有限公司 IFN-γ基因片段及其应用

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5235033A (en) 1985-03-15 1993-08-10 Anti-Gene Development Group Alpha-morpholino ribonucleoside derivatives and polymers thereof
US5034506A (en) 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
US9528160B2 (en) 2008-11-07 2016-12-27 Adaptive Biotechnolgies Corp. Rare clonotypes and uses thereof
US9506119B2 (en) 2008-11-07 2016-11-29 Adaptive Biotechnologies Corp. Method of sequence determination using sequence tags
EP2364368B1 (en) 2008-11-07 2014-01-15 Sequenta, Inc. Methods of monitoring conditions by sequence analysis
EP2567226B1 (en) 2010-05-06 2016-08-10 Adaptive Biotechnologies Corporation Monitoring health and disease status using clonotype profiles
US10385475B2 (en) 2011-09-12 2019-08-20 Adaptive Biotechnologies Corp. Random array sequencing of low-complexity libraries
EP2768982A4 (en) 2011-10-21 2015-06-03 Adaptive Biotechnologies Corp QUANTIFICATION OF ADAPTIVE IMMUNOCELL GENOMES IN A COMPLEX MIX OF CELLS
US9499865B2 (en) 2011-12-13 2016-11-22 Adaptive Biotechnologies Corp. Detection and measurement of tissue-infiltrating lymphocytes
EP3372694A1 (en) 2012-03-05 2018-09-12 Adaptive Biotechnologies Corporation Determining paired immune receptor chains from frequency matched subunits
HUE029357T2 (en) 2012-05-08 2017-02-28 Adaptive Biotechnologies Corp Preparations and devices for measuring and calibrating amplification distortion in multiplex PCR reactions
JP2015519081A (ja) 2012-06-11 2015-07-09 シーケンタ インコーポレイテッド 配列タグを用いた配列決定法
SG11201408128WA (en) 2012-06-15 2015-01-29 Adaptive Biotechnologies Corp Uniquely tagged rearranged adaptive immune receptor genes in a complex gene set
EP3330384B1 (en) 2012-10-01 2019-09-25 Adaptive Biotechnologies Corporation Immunocompetence assessment by adaptive immune receptor diversity and clonality characterization
WO2015160439A2 (en) 2014-04-17 2015-10-22 Adaptive Biotechnologies Corporation Quantification of adaptive immune cell genomes in a complex mixture of cells
JP6513035B2 (ja) 2013-02-22 2019-05-15 アダプティヴ バイオテクノロジーズ コーポレーション 希少クロノタイプおよびその用途
KR20150132479A (ko) 2013-03-15 2015-11-25 어댑티브 바이오테크놀로지스 코포레이션 복합 유전자 세트에서의 독특하게 태그되고 재배열된 적응 면역 수용체 유전자
US9708657B2 (en) 2013-07-01 2017-07-18 Adaptive Biotechnologies Corp. Method for generating clonotype profiles using sequence tags
AU2014337063A1 (en) 2013-10-18 2016-05-19 Adaptive Biotechnologies Corp. Predicting patient responsiveness to immune checkpoint inhibitors
US20160340729A1 (en) 2014-01-10 2016-11-24 Adaptive Biotechnologies Corp. Methods for defining and predicting immune response to allograft
US11390921B2 (en) 2014-04-01 2022-07-19 Adaptive Biotechnologies Corporation Determining WT-1 specific T cells and WT-1 specific T cell receptors (TCRs)
US10066265B2 (en) 2014-04-01 2018-09-04 Adaptive Biotechnologies Corp. Determining antigen-specific t-cells
CA2966201A1 (en) 2014-10-29 2016-05-06 Adaptive Biotechnologies Corp. Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from many samples
US10246701B2 (en) 2014-11-14 2019-04-02 Adaptive Biotechnologies Corp. Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture
AU2015353581A1 (en) 2014-11-25 2017-06-15 Adaptive Biotechnologies Corporation Characterization of adaptive immune response to vaccination or infection using immune repertoire sequencing
AU2016243583B2 (en) * 2015-03-27 2022-03-10 President And Fellows Of Harvard College Modified T cells and methods of making and using the same
EP3277294B1 (en) 2015-04-01 2024-05-15 Adaptive Biotechnologies Corp. Method of identifying human compatible t cell receptors specific for an antigenic target
WO2017112944A1 (en) 2015-12-23 2017-06-29 Fred Hutchinson Cancer Research Center High affinity t cell receptors and uses thereof
SG11202004026QA (en) * 2017-10-30 2020-05-28 Pact Pharma Inc Primary cell gene editing
US12359179B2 (en) * 2018-12-12 2025-07-15 The Regents Of The University Of California Compositions and methods for modifying a target nucleic acid
JP2024512608A (ja) 2021-03-24 2024-03-19 ジェネンテック， インコーポレイテッド Ｔリンパ球における効率的なｔｃｒ遺伝子編集

Similar Documents

Publication Publication Date Title
US12258397B2 (en) Production of engineered T-cells by sleeping beauty transposon coupled with methotrexate selection
JP2024512608A5 (https=)
US11896616B2 (en) Stimulatory cell lines for ex vivo expansion and activation of natural killer cells
CN118389602B (zh) 经人工操纵的免疫细胞
CN111655719A (zh) 内源性t细胞受体的靶向置换
CN106544321A (zh) 通用型car‑t细胞及其制备方法和用途
US12492386B2 (en) Methods to enrich genetically engineered T cells
CN102027104A (zh) 含有细胞因子诱导杀伤细胞的细胞群的制造方法
JP7043114B2 (ja) 細胞を活性化させるための方法およびキット
EP3784774B1 (en) Methods of producing t cell populations using hydroxycitric acid and/or a salt thereof
CN117417894A (zh) 敲除Roquin-1和/或Regnase-1基因的肿瘤浸润淋巴细胞及其应用
JP2023538418A (ja) 腫瘍浸潤性リンパ球からの抗原特異的ＴＣＲを有するｉＰＳＣの優先的生成
RU2023124728A (ru) Эффективное редактирование генов tcr в т-лимфоцитах
CA2945302C (en) Defined composition gene modified t-cell products
JP2023529443A (ja) 抗ｃｄ１７１キメラ抗原受容体
HK40027138A (en) Artificially manipulated immune cell
HK40027138B (zh) 经人工操纵的免疫细胞